Oct 9 (Reuters) - HHS:
* BIDEN-HARRIS ADMINISTRATION TAKES NEXT STEP ON PROPOSED MODEL TO LOWER PRESCRIPTION DRUG COSTS FOR PEOPLE WITH MEDICARE
* HHS: CMS SEEKS FEEDBACK ON MEDICARE $2 DRUG LIST MODEL, SAMPLE $2 DRUG LIST, AND OUTREACH
* HHS: PARTICIPATION IN MODEL WOULD BE VOLUNTARY FOR PART D SPONSORS & COULD START AS EARLY AS JAN 2027
* HHS: CMS INTENDS TO INCLUDE MANY DRUGS USED TO TREAT COMMON CONDITIONS FOR PEOPLE WITH MEDICARE, WITH PERIODIC UPDATES TO DRUG LIST ONCE FINALIZED
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST, PRIOR TO LAUNCH OF MODEL
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST AT INTERVALS IN MODEL LIFESPAN
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.